Annals of Hematology

Show Articles
Journal Properties
  • Formerly known as
    Hematology and Cell Therapy, Folia haematologica; internationales Magazin fur Blutforschung, Folia Haematologica, Blut
  • Country
    Germany
  • Language
    English
  • Number of Articles
    7,919
  • Abbreviation
    Ann Hematol
  • ISSN
    0939-5555
  • e-ISSN
    1432-0584
  • Main Publisher
    Springer Nature
  • Publisher
    Springer Science and Business Media LLC
  • Indian UGC
  • Indian UGC Name
  • DOAJ (latest)
Journal Properties
  • Medicine
    Internal medicine
    Specialties of internal medicine
    Diseases of the blood and blood-forming organs
    Medicine
    Internal medicine
    Specialties of internal medicine
    Diseases of the circulatory (Cardiovascular) system
    Medicine
    Medicine (General)
  • website
Description
The Annals of Hematology is an international journal dedicated to the latest advancements in clinical and experimental hematology. It presents high-quality research on blood-related disorders, including leukemia, lymphoma, myeloma, anemia, and thrombosis. Focusing on innovative diagnostic and therapeutic approaches, the journal serves as a key resource for hematologists, oncologists, and researchers worldwide. Coverage includes but is not limited to the pathophysiology, diagnosis, and treatment of hematological malignancies, benign hematologic disorders, stem cell transplantation, and transfusion medicine. It features original articles, reviews, case reports, and letters to the editor. The journal is indexed in major databases, such as CAS, Scopus, and Web of Science, ensuring broad visibility and accessibility for its content. The Annals of Hematology targets a wide audience, including clinicians, researchers, and academics specializing in hematology and related fields. With a commitment to advancing the understanding and treatment of blood disorders, Annals of Hematology encourages submissions that contribute significantly to the field. It aims to foster international collaboration and improve patient outcomes through the dissemination of cutting-edge research. Open access options are available, further enhancing the journal’s reach and impact within the scientific community.